Cargando…
The level of HER2 expression is a predictor of antibody-HER2 trafficking behavior in cancer cells
The receptor tyrosine kinase HER2 is known to play a central role in mitogenic signaling, motivating the development of targeted, HER2-specific therapies. However, despite the longstanding use of antibodies to target HER2, controversies remain concerning antibody/HER2 trafficking behavior in cancer...
Autores principales: | Ram, Sripad, Kim, Dongyoung, Ober, Raimund J, Ward, E Sally |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622696/ https://www.ncbi.nlm.nih.gov/pubmed/25517306 http://dx.doi.org/10.4161/mabs.29865 |
Ejemplares similares
-
Selective depletion of radiolabeled HER2-specific antibody for contrast improvement during PET
por: Khare, Priyanka, et al.
Publicado: (2021) -
Engineering a HER2-specific antibody-drug conjugate to increase
lysosomal delivery and therapeutic efficacy
por: Kang, Jeffrey C., et al.
Publicado: (2019) -
Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody
por: Cheng, Jackie, et al.
Publicado: (2020) -
Engineering multivalent antibodies to target heregulin-induced HER3 signaling in breast cancer cells
por: Kang, Jeffrey C, et al.
Publicado: (2014) -
Ultrahigh accuracy imaging modality for super-localization microscopy
por: Chao, Jerry, et al.
Publicado: (2013)